The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review.
De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M.
De Berardis D, et al. Among authors: de bartolomeis a.
CNS Neurol Disord Drug Targets. 2013 Mar;12(2):252-64. doi: 10.2174/1871527311312020012.
CNS Neurol Disord Drug Targets. 2013.
PMID: 23469841
Review.